Tofacitinib
- Product NDC
- 72205-139
- Requested package NDC
- 72205-139-60
- 11-digit product format
- 722050139
- Labeler code
- 72205
- Product ID
- 72205-139_253635c8-1ea7-41ba-b216-dea5e3305c47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tofacitinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Novadoz Pharmaceuticals LLC
- Application
- ANDA217299
- Marketing category
- ANDA
- Marketing start
- 2026-06-03
- Substance
- TOFACITINIB CITRATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217299-001 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | |
| A217299-002 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217299-001 | AB |
| A217299-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217299-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217299-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217299-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217299-002 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tofacitinib
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOFACITINIB CITRATE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O1FF4DIV0D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 253635c8-1ea7-41ba-b216-dea5e3305c47 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 217299 ANDA217299 |
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-06-06 | Boxed warning, Warnings, Adverse reactions | 217299 ANDA217299 72205-139-60 72205-139 72205013960 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Status |
|---|---|---|---|---|---|
| 72205-139-60 | 72205013960 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-139-60) | 2026-06-03 | 0 | Current |